Thermo Fisher Scientific (TMO) Receivables - Net (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Receivables - Net for 18 consecutive years, with $9.2 billion the latest figure, recorded in Q1 2026.

• Receivables - Net for Q1 2026 came in at $9.2 billion, up 8.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.2 billion (up 8.86% YoY), and the FY2025 annual result was $8.9 billion, up 8.66% from the prior year.
• Receivables - Net was $9.2 billion for Q1 2026 at Thermo Fisher Scientific, up from $8.9 billion in the prior quarter.
• Over five years, Receivables - Net peaked at $9.2 billion in Q1 2026 and troughed at $7.7 billion in Q4 2022.
• Average Receivables - Net over 5 years is $8.3 billion, with a median of $8.2 billion recorded in 2024.
• Year-over-year, Receivables - Net soared 42.04% in 2022 and slipped 1.37% in 2024.
• Over 5 years, Receivables - Net stood at $8.1 billion in 2022, then climbed by 1.31% to $8.2 billion in 2023, then decreased by 0.36% to $8.2 billion in 2024, then grew by 8.66% to $8.9 billion in 2025, then gained by 3.42% to $9.2 billion in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $9.2 billion in Q1 2026, $8.9 billion in Q4 2025, and $8.9 billion in Q3 2025.